These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

202 related items for PubMed ID: 17430259

  • 1. Effects of olprinone, a phosphodiesterase III inhibitor, on ischemic acute renal failure.
    Anas C, Ozaki T, Maruyama S, Yamamoto T, Zu Gotoh M, Ono Y, Matsuo S.
    Int J Urol; 2007 Mar; 14(3):219-25. PubMed ID: 17430259
    [Abstract] [Full Text] [Related]

  • 2. The enhancement of cellular cAMP with olprinone protects autotransplanted rat kidney against cold ischemia-reperfusion injury.
    Zhang Y, Ma Q.
    Transplant Proc; 2006 Jun; 38(5):1580-3. PubMed ID: 16797361
    [Abstract] [Full Text] [Related]

  • 3. Effect of phosphodiesterase III inhibitor (Olprinone) on thoracic duct lymph flow in anesthetized sheep with experimentally induced heart failure by endothelin-1.
    Tomoyasu M, Onizuka M, Inagaki M, Sato Y, Yamamoto T, Ishikawa S, Mitsui T.
    Lymphology; 2002 Dec; 35(4):144-52. PubMed ID: 12570323
    [Abstract] [Full Text] [Related]

  • 4. The effects of the phosphodiesterase inhibitor olprinone on global cerebral ischemia.
    Okayama N, Matsunaga A, Kakihana Y, Fujikawa K, Inoue K, Nagayama T, Takeyama M, Miyata A, Kanmura Y.
    Anesth Analg; 2010 Mar 01; 110(3):888-94. PubMed ID: 20042441
    [Abstract] [Full Text] [Related]

  • 5. Neuroprotective effects of olprinone after cerebral ischemia/reperfusion injury in rats.
    Genovese T, Mazzon E, Paterniti I, Esposito E, Cuzzocrea S.
    Neurosci Lett; 2011 Oct 03; 503(2):93-9. PubMed ID: 21872644
    [Abstract] [Full Text] [Related]

  • 6. Effect of olprinone, a phosphodiesterase III inhibitor, on hepatic ischemia-reperfusion injury in rats.
    Yamaguchi K, Kawahara T, Kumakura S, Hua J, Kugimiya T, Nagaoka I, Inada E.
    Shock; 2010 Apr 03; 33(4):436-41. PubMed ID: 19730166
    [Abstract] [Full Text] [Related]

  • 7. Effects of dopamine and olprinone on ventricular energetics in sevoflurane-induced acute left ventricular depression in dogs.
    Iwade M, Nomura M, Uezono S, Ashikari E, Ozaki M.
    J Cardiothorac Vasc Anesth; 2006 Jun 03; 20(3):358-63. PubMed ID: 16750736
    [Abstract] [Full Text] [Related]

  • 8. Intrarenal administration of recombinant human soluble thrombomodulin ameliorates ischaemic acute renal failure.
    Ozaki T, Anas C, Maruyama S, Yamamoto T, Yasuda K, Morita Y, Ito Y, Gotoh M, Yuzawa Y, Matsuo S.
    Nephrol Dial Transplant; 2008 Jan 03; 23(1):110-9. PubMed ID: 17804460
    [Abstract] [Full Text] [Related]

  • 9. Dynamic changes of post-ischemic hepatic microcirculation improved by a pre-treatment of phosphodiesterase-3 inhibitor, milrinone.
    Kume M, Banafsche R, Yamamoto Y, Yamaoka Y, Nobiling R, Gebhard MM, Klar E.
    J Surg Res; 2006 Dec 03; 136(2):209-18. PubMed ID: 17045613
    [Abstract] [Full Text] [Related]

  • 10. Macrophages contribute to the initiation of ischaemic acute renal failure in rats.
    Jo SK, Sung SA, Cho WY, Go KJ, Kim HK.
    Nephrol Dial Transplant; 2006 May 03; 21(5):1231-9. PubMed ID: 16410269
    [Abstract] [Full Text] [Related]

  • 11. Hyperbaric oxygen therapy attenuates renal ischemia/reperfusion injury in rats.
    Solmazgul E, Uzun G, Cermik H, Atasoyu EM, Aydinoz S, Yildiz S.
    Urol Int; 2007 May 03; 78(1):82-5. PubMed ID: 17192739
    [Abstract] [Full Text] [Related]

  • 12. Olprinone reduces ischemia/reperfusion-induced acute renal injury in rats through enhancement of cAMP.
    Mizutani A, Murakami K, Okajima K, Kira S, Mizutani S, Kudo K, Takatani J, Goto K, Hattori S, Noguchi T.
    Shock; 2005 Sep 03; 24(3):281-7. PubMed ID: 16135969
    [Abstract] [Full Text] [Related]

  • 13. Possible mechanisms underlying the vasodilatation induced by olprinone, a phosphodiesterase III inhibitor, in rabbit coronary artery.
    Ohashi M, Dohi Y, Itoh T.
    Br J Pharmacol; 2000 Mar 03; 129(5):1000-6. PubMed ID: 10696101
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Olprinone, a PDE3 inhibitor, modulates the inflammation associated with myocardial ischemia-reperfusion injury in rats.
    Di Paola R, Mazzon E, Paterniti I, Impellizzeri D, Bramanti P, Cuzzocrea S.
    Eur J Pharmacol; 2011 Jan 15; 650(2-3):612-20. PubMed ID: 21035441
    [Abstract] [Full Text] [Related]

  • 17. Experimental study on early protective effect of ischemic preconditioning on rat kidney graft.
    Jia RP, Zhu JG, Wu JP, Xie JJ, Xu LW.
    Transplant Proc; 2009 Jan 15; 41(1):69-72. PubMed ID: 19249479
    [Abstract] [Full Text] [Related]

  • 18. Olprinone, a phosphodiesterase III inhibitor, reduces gut mucosal injury and portal endotoxin level during acute hypoxia in rabbits.
    Satoh T, Morisaki H, Ai K, Kosugi S, Yamamoto M, Serita R, Kotake Y, Takeda J.
    Anesthesiology; 2003 Jun 15; 98(6):1407-14. PubMed ID: 12766650
    [Abstract] [Full Text] [Related]

  • 19. Posttreatment with aminoguanidine attenuates renal ischemia/reperfusion injury in rats.
    Onem Y, Ipcioglu OM, Haholu A, Sen H, Aydinoz S, Suleymanoglu S, Bilgi O, Akyol I.
    Ren Fail; 2009 Jun 15; 31(1):50-3. PubMed ID: 19142810
    [Abstract] [Full Text] [Related]

  • 20. Lipopolysaccharide-induced acute renal failure in conscious rats: effects of specific phosphodiesterase type 3 and 4 inhibition.
    Jonassen TE, Graebe M, Promeneur D, Nielsen S, Christensen S, Olsen NV.
    J Pharmacol Exp Ther; 2002 Oct 15; 303(1):364-74. PubMed ID: 12235272
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.